-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Xenon Pharmaceuticals, Raises Price Target to $80

Benzinga·05/12/2026 15:13:37
Listen to the news
JP Morgan analyst Tessa Romero maintains Xenon Pharmaceuticals (NASDAQ:XENE) with a Overweight and raises the price target from $77 to $80.